Results 161 to 170 of about 127,348 (379)

The Impact of Methotrexate on Cardiovascular Outcomes in Psoriasis: A Systematic Review and Meta‐Analysis

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Psoriasis is a chronic immune‐mediated inflammatory disease with a global prevalence of 2%–3% and 1.3% in Brazil. It is associated with comorbidities such as obesity, hypertension, and diabetes, all of which contribute to increased cardiovascular risk due to systemic inflammation and endothelial dysfunction.
Tiago A. S. Costa   +2 more
wiley   +1 more source

Characteristics of Adult Patients With Atopic Dermatitis Initiating Biologics and Janus Kinase Inhibitors in the CorEvitas Atopic Dermatitis Registry

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Biologics and Janus kinase inhibitors (JAKi) are two advanced systemic treatment options for patients with atopic dermatitis (AD). The decision to initiate one of these therapies is complex and may be driven by many factors.
Eric L. Simpson   +12 more
wiley   +1 more source

Analysis on effects of different treatment regimens for patients with IgA nephropathy

open access: yesLinchuang shenzangbing zazhi, 2019
Objective To study the clinical efficacy and safety of different western medicine regimens for the treatment of IgA nephropathy. Methods A total of 72 patients with IgA nephropathy admitted to Gaozhou people’s hospital from January 2016 to June 2018 were
ZHU Ming-zhi, ZHONG Rui-qiong, TONG Yu
doaj  

Pancreatic transplantation at the University of Pittsburgh. [PDF]

open access: yes, 2004
Campath-1H preconditioning with tacrolimus monotherapy is an effective immunosuppressive regimen for pancreas transplantation, with acceptable patient and graft survival rates early after transplantation.
Abu-Elmagd, K   +12 more
core  

Mycophenolate mofetil in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis: a prospective pharmacokinetics and clinical study [PDF]

open access: bronze, 2013
Benjamin Chaigne   +16 more
openalex   +1 more source

Home - About - Disclaimer - Privacy